Key points are not available for this paper at this time.
Hans-Georg Eichler from the European Medicines Agency and colleagues provide a view from regulators on access to clinical trial data.
Share your take
Add a clinician perspective alongside expert commentary.
Eichler et al. (Tue,) studied this question.